mRNA vaccine reduces melanoma relapses, trials show

An mRNA vaccine developed by Merck and Moderna extends remission in melanoma patients.

Published 1j1 sourceImportant

≈ 17sSpeed

The fact

Clinical trials show a reduction in relapses for patients with this aggressive skin cancer.

This breakthrough could transform treatment for aggressive cancers.

Click the link to read an article on the topic:

Explore this topic

Auto-synthesis from 1 media source · identified on August 21, 2026